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ABSTRACT The a subunit of the g nucleotide-
binding protein G. ("o" for other) is believed to mediate signal
transduction between a variety of receptors and effectors.
cDNA clones encoding two forms of G. a subunit were isolated
from a mouse brain library. These two forms, which we call
G0Aa and GBa, appear to be the products of alternative
splicing. G0Aa differs from G0Ba over the C-terminal third of
the deduced protein sequence. Both forms are predicted to be
substrates for ADP-ribosylation by pertussis toxin. G0Aa
transcripts are present in a variety of tissues but are most
abundant in brain. The GBa transcript is expressed at highest
levels in brain and testis. It is possible that G0Aa and G Ba
have different functions.
Guanine nucleotide-binding proteins (G proteins) form a large
family of signal-transducing molecules. They are found as
heterotrimers made up of a, /3, and y subunits. Members of
the G protein family have been most extensively character-
ized by the nature of the a subunit, which binds guanine
nucleotide, is capable of hydrolyzing GTP, and interacts with
specific receptor and effector molecules (for reviews, see
refs. 1-3). A variety of specific G protein a subunits and their
corresponding cDNAs and genes have been identified. Some
of the a subunits, such as stimulatory G protein (Gs) a
subunit, are ubiquitous-i.e., splice variants of the Gs a
subunit gene (4) are found in every tissue that has been
examined. In reconstitution experiments, Gs a subunit was
shown to interact with a specific subset of receptors and to
activate adenylate cyclase. Other G proteins are cell-type
specific-i.e., they are found in specialized cells and appear
to transduce signals from only a small subset of receptors.
For example, there are two transducins, one found only in
rod photoreceptor cells and the other found only in cone cells
(5, 6). Still other members of the a-subunit family are
restricted to a subset of tissues.
In the course of the purification of inhibitory G protein (Gi)
subunits, a new G protein was discovered and named Go ("o"
for other). The Go heterotrimer is found abundantly in bovine
brain as a membrane-associated protein (7, 8). Homologues
of the Go a subunit have been found in a variety of organisms
from Drosophila to man (2, 9-12). In general, the Go protein
is localized in neural tissue and is an abundant membrane-
bound protein in brain extracts. Evidence for the presence of
Go in some other tissues has also been obtained, but the
highest concentration of both protein and mRNA appears to
be in brain. The purified Go a subunit has been used to
reconstitute signal transducing systems, and it has been
proposed to be the G protein that mediates a variety of
processes that are sensitive to pertussis toxin inhibition (see
ref. 13 for review). Perhaps the clearest evidence for the
specific involvement of Go comes from studies on ion chan-
nels in neuronal cells and heart atria. There is evidence from
patch-clamp studies that the GTP-bound Go a subunit can
gate potassium and calcium channels (14-17). It also has been
suggested that the pertussis toxin-sensitive activation of
phospholipase C may be mediated by Go a subunit (18, 19).
Recently, the GAP 43 protein in nerve growth cones was
shown to stimulate guanine 5'-[ythio]triphosphate binding to
Go (20). Thus, there are indications that a large variety of
receptors and effectors could interact with the Go a subunit.
The cDNA corresponding to Go a subunit has been isolated
and characterized from ,a number of different organisms (13).
The gene itself is large, containing at least 10 exons that cover
>90 kilobase pairs (kbp) ofDNA in humans (21). During the
course of studies to ascertain the diversity of the G protein a
subunit family, we discovered cDNA clones encoding a
variant form of mouse brain Go a subunit. The sequences of
the two forms are identical at the N terminus but show
considerable variation at the C terminus*. These two forms
of mouse brain Go a subunit, which we call G0Aa and GOBa,
are likely the products of alternative splicing, and they may
have different functions.
MATERIALS AND METHODS
Polymerase Chain Reaction (PCR). PCR (22) was performed
as described (23). Mouse brain and spermatid cDNA were
made from poly(A)+ RNA with random hexanucleotide prim-
ers by using Moloney murine leukemia -virus reverse tran-
scriptase. Conditions were those supplied by the manufacturer
(BRL). The oligonucleotides used forPCR amplification ofthe
cDNA were as follows: oMP19, CGGATCCAARTGGATH-
CAYTGYTT; oMP20, GGAATTCRTCYTTYYJTRTrNAGR-
AA; oMP21, GGAATTCRTCYTTYTTRTTYAARAA;
CT60,CATGCACGAATCCCTGAAGC; CT112, CCGCATG-
CACGAGTCTCTCAT; CT113, CCCGKAGRTTKTTGGC-
RATGA; CT114, ATGGGATGTACGCTGAGCGCA; GO1,
TCGTCCTCGTGGAGCACCTG; and Ta29, GGGATCCNG-
TRTCNGTNGCRCANGT, in which R = A or G, Y = C or T,
K = G or T, H = A, C, or T, and N = A, C, G, or T. PCR was
performed on a Perkin-Elmer/Cetus thermal cycler. During
each cycle, samples were denatured for 1.0 min at 940C,
extended for 1.0 min at 720C, and annealed for 0.5 min at the
following temperatures; oMP19 + oMP20 + oMP21, at 420C;
CT60 + Ta29, at 50°C; oMP19 + Ta29, at 420C; GO1 + CT114,
at 600C; CT60 + CT113, at 550C; and CT112 + CT113, at 550C.
Each oligonucleotide was used in the PCR at 10 ng/pul; 35
cycles were performed on approximately 5 ng of cDNA in a
50-S l reaction volume. The buffer and Thermus aquaticus
(Taq) polymerase were supplied by Cetus.
Abbreviations: PCR, polymerase chain reaction; G protein, guanine
nucleotide-binding protein; G;, Gs, and Go, inhibitory, stimulatory,
and"other" G proteins.
*The sequences reported in this paper have been deposited in the
GenBank data base (accession nos. M36777 for G0Aa and M36778
for GOBa).
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Northern Analysis. Total RNA and poly(A)+ RNA were run specific to GOAa or GOBa were made by PCR amplifying G011
on 1% agarose gels and transferred to GeneScreen (DuPont) and 718-52-4 (Fig. 1B) with oligonucleotide pairs CT112 +
as described (24). A probe specific to both GOAa and GOBa CT113 (GOAa) and CT60 + CT113 (GOBa). The amplified
was made by PCR amplifying clone G011 (Fig. 1A) with products were run on low-melting-point agarose gels (Sea-
oligonucleotides GO1 and CT114 as described above. Probes plaque, FMC), excised, and labeled by random priming as
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1657 GCTCCCCAGGATACTCAGCCCTGACTCCCATGGGGTTGGGAATATTCCTTAAGACTGGCT 1716
1717 GACTGCAAAGGTCACCGATGGAGAAACATCCCTGTGCTACAGAATTGGGGGTGGGACAGC 1776
1777 TGAGGGGGCAGGCGGCTCTTTCCTGATAGTTGATGACAAGCCCTGAGAATGCCATCTGCT 1836
1837 GGCTCCACTCACACGGGCTCAACTGTCCTGGGTGATAGTGACTTGCCAGGCCACAGGCTG 1896
1897 CAGGTCACAGACAGAGCAGGCAAGCAGCCTTGCAACTGCAGATTACTTAGGGAGAAGCAT 1956
2197 CCTAGCCCCAGCTAACTTTGGACAGTCAGCATATGTCCCTGCCATCCCTAGACATCTCCA 2256
2257 GTCAGCTGGTATCACAGCCAGTGGTTCAGACAGGTTTGAATGCTCATGTGGCAGGGGGCC 2316
2317 CGGTACCCAGCTTTTGTTCCCTTTAGTGAGGGTTAATTGCGCGCTTGGGCTAATCATGGT 2376
2377 CATAGCTGTTGGGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCTGACGAGATCACAA 2436
2437 AAATCGACGCTCAAGTCAGAGGTGGCGAAACCGACAGACTATAAGATACCAGGC 2490
FIG. 1. Sequences of G0Aa (A) and GOBa (B). (A) The sequence of G.Aa was obtained from two clones,G011 and G012. These clones were
isolated from a random-primed mouse brain cDNA library.G011 extends from nucleotide -21 to 1133.G012 includes nucleotides 616-1888.G011
differs from G 12 beginning at base 1093. These changes are shown below the G.12 sequence. (B) The GOBa sequence is contained in two clones,
718-52-4 and 7i8-52-5. These clones were isolated from the same library as the G.Aa clones. Clone 718-52-5 extends from nucleotide -23 to
903. Clone 718-52-4 extends from nucleotide 822 to 2490. Oligonucleotides mentioned in the text are indicated above the sequence.
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described (23). The RNA blots were hybridized as described
(23).
PCR Northern Analysis. PCR was performed on cDNA
from total RNA as described above. The degenerate oligo-
nucleotides oMP19, oMP20, and oMP21 were used for 30
cycles of amplification. The PCR products were electropho-
resed through a 2% agarose gel, blotted to GeneScreen, and
hybridized according to the manufacturer's instructions.
These blots were probed with radiolabeled oligonucleotides
specific to Gall (CTCGCTTAGTGCCACC), GoAa (GAG-
CATGAGAGACTCG), and GoBa (GAGCTTCAGGGAT-
TCG). The oligonucleotides were end-labeled with [t-32P]-
ATP as described (24). Blots were washed at room temper-
ature twice for 5 min in 0.90 M NaCl/0.09 M sodium citrate
(6x SSC)/0.1% SDS (24), twice for 5 min in 6x SSC, and
finally for 1 min in 6x SSC at the melting temperature of each
oligonucletoide.
Isolation of cDNAs and Nucleotide Sequencing. A random-
hexanucleotide-primed mouse brain cDNA library in the
cloning vector mAJSM8 (M.S. and M.I.S., unpublished data)
was screened by standard techniques. Sequencing was per-
formed by using the Sequenase kit marketed by United States
Biochemical.
RESULTS
Cloning GOAa and G0Ba cDNAs. PCR was used to screen
RNA from both mouse brain and mouse spermatids for
messages that correspond to different G protein a subunits
(24). Degenerate oligonucleotides that code for amino acid
sequences conserved in a subunits were used for amplifica-
tion. These conserved amino acid sequences are shown in
Fig. 1A (oMP19, oMP20, oMP21). The DNA sequences of
clones derived from the PCR were determined. Two different
classes ofDNA sequences were found to encode amino acid
sequences that correspond to the Go a protein. Multiple
clones of these two classes, termed PCRG-8 and PCRG-12,
were obtained from both brain and spermatid cDNA. The
derived amino acid sequence of PCRG-8 is identical to that
found for the Go a subunit cDNA from rat olfactory tissue
(25). However, the sequence of PCRG-12 is identical to
PCRG-8 only for the first 89 nucleotides and then diverges.
To obtain a specific probe for the PCRG-12 gene sequence,
we amplified mouse spermatid cDNA with oMP19 and an-
other degenerate oligonucleotide, Ta29, which encodes con-
served amino acids near the C terminus ofa subunits (2). The
PCR products were subcloned and screened with the PCRG-
12-specific oligonucleotide, CT60 (Fig. 1B). The DNA se-
quence of one positive clone, 718-52, was found to be
identical to PCRG-12, and it extended the sequence 168
nucleotides downstream. A hybridization probe was pre-
pared from clone 718-52 by PCR with CT60 and Ta29 as
primers. This probe and PCRG-8 were used to screen a
randomly primed mouse brain cDNA library. Several cDNA
clones were purified and sequenced. The complete DNA
sequences of the mouse GoAa cDNA and the mouse GoBa
cDNA are presented in Fig. 1. The amino acid sequence of
mouse GoAa differs from that of the rat Go a subunit (25) at
two positions (Thr-102 -- Ala and Gly-166 -* Ala). However,
the DNA sequence of the GoBa clone differs markedly from
that of GoAa in the region corresponding to the C-terminal
third of the reading frame and the 3' untranslated region. The
DNA sequence is identical in the portion of the clone that
corresponds to the N-terminal two-thirds of the protein and
the 5' untranslated region.
Another variant of the G_ a subunit cDNA clone was
obtained whose sequence was identical to that of the GOAa
clones throughout the translated portion of the cDNA but
varied from the GOAa cDNA in the 3' untranslated region of
the sequence. The DNA sequence of the variable region is
shown in Fig. 1A.
The nucleotide sequence of the GoAa cDNA clone and that
of the GoBa cDNA clone are identical up to position 737.
Thereafter some sequence conservation exists until a point
corresponding to nucleotide 1064, which marks the end ofthe
reading frame. In the 3' untranslated region, the sequence of
G0Aa and GoBa differ dramatically from each other. It seems
likely that GoAa and GoBa reflect different splice products
derived from the same gene. Further support for this idea is
provided by the intron-exon map of the Go a subunit gene
reported by Kaziro (21), which shows the same distribution
of introns and exons as in the G, a subunit gene. If the GoAa
and G.Ba gene products were the result ofdifferential mRNA
splicing, then we would expect the divergence point to be at
nucleotide 723. This corresponds to an asparagine residue in
both protein sequences. The first change in DNA sequence
occurs at nucleotide 737 of the GoAa sequence. On the basis
of this interpretation, Fig. 2 shows the distribution of amino
acid sequences corresponding to the nucleotide sequences of
the GoAa and GoBa clones: after the point of divergence,
there are 25 differences between the amino acid sequences,
and 17 of them are concentrated within a stretch of 32 amino
acids.
Distribution of G. Gene Product. Tissue distribution of
GoAa and GoBa mRNAs was analyzed first by Northern
blots. Poly(A)+ and total RNA from a variety of mouse
tissues were separated by electrophoresis and hybridized to
each of three probes that were obtained from the cDNA
clones. These probes were made by PCR amplification of the
5'-end sequences shared by both GoAa and GoBa or by
amplification of regions unique to either G0Aa or GoBa.
Hybridization of the probe that is common to both splice
products was compared with hybridization of the probes
specific to GoAa or GoBa (Fig. 3). G. a subunit mRNA was
most abundant in brain (Fig. 3A), and on a longer exposure,
six distinct transcripts were visible (Fig. 3B). These tran-
scripts were also expressed at lower levels in testis, heart,
and lung but were not observed in other tissues when assayed
by Northern blot. The GoAa probe specifically hybridized to
the three smallest transcripts that were identified by the
common probe. GoAa was most abundant in brain but also
was expressed in testis and heart (Fig. 3C). In contrast, GoBa
specifically hybridized to one transcript at equal intensity in
brain and testis (Fig. 3D). On longer exposures, the largest
transcripts could be seen to hybridize to both probes (data not
shown) and may represent unspliced or partially spliced
precursors derived from nuclear RNA. Thus, each transcript
that hybridizes to the common probe is also recognized by
either the GoAa- or GoBa-specific probe. The relative levels
of GoAa and GoBa transcripts in a specific tissue can be
estimated by comparing the relative intensities of the GoBa-
specific message and the GoAa transcripts (Fig. 3B). GoAa
was much more abundant than GoBa in brain, whereas the
levels of the two transcripts were similar in testis.
We used a technique based on PCR amplification that is
more sensitive than Northern analysis (T.M.W., unpublished
data) to get a clearer picture of the distribution and relative
abundance of GoAa and GoBa mRNAs. cDNA from various
tissues was amplified by PCR by using the degenerate oligo-
nucleotides oMP19 in combination with oMP20 and oMP21.
The amplified products were electrophoresed and stained
with ethidium bromide. All tissues had an amplified band of
the same size, indicating that they all express G protein a
subunit mRNA. A second assay (Fig. 4) also was used to
demonstrate that each tissue supported the PCR reaction.
Southern blots of the PCR products were hybridized with an
oligonucletoide probe that is specific to the G protein a
subunit designated Gall. This protein is expressed ubiqui-
tously (24). All tissues expressed roughly the same amount of
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FIG. 2. Comparison of G0Aa and GOBa amino acid sequences. Differences in amino acid residues are indicated by stars between the two
sequences. A, C, G, and I represent domains that have been implicated in guanine nucleotide interactions (2).
Gall with the exception of uterus, which might reflect a
lower level ofGall in this RNA source. Southern blots of the
PCR products were also hybridized with oligonucletoide
probes specific to either GOAa or GOBa (Fig. 4). G.Aa was
most abundant in brain, followed by testis, heart, skeletal
muscle, and uterus. GOAa was also expressed at low levels
in intestine, kidney, and lung and at exceedingly low levels in
spleen and thymus; it was undetectable in liver. These cDNA
samples were also amplified by PCR with oligonucleotide
primers specific to G0Aa. The results showed the same
relative distribution pattern of G.Aa transcripts in the dif-
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ferent tissues (data not shown). In contrast, GoBa was
expressed primarily in brain and testis and to a lesser extent
in lung, but other tissues expressed little or no GoBa mRNA.
The expression pattern ofGoAa and GoBa was corroborated
by PCR analysis using a second set of independently isolated
RNA samples. The relative levels of either GoAa or GoBa
expressed in brain and testis and assayed by PCR agreed with
the Northern analysis.
DISCUSSION
The Go a subunit gene is a complex locus including more than
10 exons and extending over 90 kbp ofDNA in humans (21).
We have demonstrated the existence in mouse of transcripts
that code for two forms of the Go a protein, G0Aa and GoBa.
The sequences of these transcripts are identical for over 700
nucleotides at their 5' ends. They diverge near an intron/
exon junction, suggesting that they are products of alterna-
tive splicing. Kaziro and coworkers have now confirmed this
interpretation by determining the organization of exons that
represent both forms (Y. Kaziro, personal communication).
Heterogeneity of proteins antigenically related to the Go a
subunit has been observed. Goldsmith et al. (27) resolved on
two-dimensional gels GoAa and another protein from bovine
brain, termed G*, that reacted with four Go a subunit-specific
antisera. However, only one of the peptide antisera used in
this study was raised against a sequence not shared by GoAa
and GoBa. This sequence, the carboxyl-terminal decapeptide
of GoAa, differs from that of GoBa at only one residue.
Consequently, this antisera may recognize GoBa. In addi-
tion, G* can be ADP-ribosylated by pertussis toxin. G.Ba is
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FIG. 3. Northern analysis ofG.Aa and GOBa. Probes specific to
both G0Aa and G.Ba [G0(A/B)a] (A and B), to G0Aa (C), and to
G.Ba (D) were hybridized to poly(A)+ and total RNA from various
mouse tissues. Total RNA (20 ,g) was loaded per lane. The poly(A)+
RNA was loaded as follows: brain, 0.5 ,ug; kidney, 5 tg; and heart,
5 ,g. B is a longer exposure of A.
FIG. 4. PCR Northern analysis. PCR was performed on various
mouse tissues with the degenerate oligonucleotides of oMP19,
oMP20, and oMP21 (Fig. 1). The amplified products were hybridized
with radiolabeled oligonucleotides specific to G0Aa, GOBa, and
Gall.
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predicted to be a substrate for pertussis toxin because the
fourth residue from the C terminus is cysteine. A cysteine
residue at this position is implicated as the site of ADP-
ribosylation in all a subunits that are sensitive to pertussis
toxin (1, 2). Thus, it is possible that G* is the G.Ba protein.
Milligan et al. (28) identified, in rat myometrical mem-
branes, a protein that reacted with two Go a subunit-specific
peptide antisera but not with an antiserum against partially
purified Go a subunit or with a peptide antiserum against
GoAa amino acids 22-35. Although we do not have sequence
data to suggest differential splicing at the N terminus ofGo a
subunit, it is interesting that the N-terminal 39 amino acids of
the Drosophila homolog are switched by an alternative
splicing mechanism (9-11).
The 3' untranslated region ofGoAa also appears to undergo
alternative splicing. We sequenced two clones that diverge 29
nucleotides past the stop codon (Fig. 1A). Murtagh et al. (29)
found two forms of the GoAa message in bovine retina that
diverge 31 nucleotides past the stop codon. The significance
of these alternately spliced 3' untranslated regions is un-
known. However, the untranslated regions of specific G
protein a subunit isotypes are highly conserved across spe-
cies (13, 30), revealing a selective pressure to maintain these
sequences. Hence, the untranslated regions may affect gene
regulation at the transcriptional or posttranscriptional level
(31).
The functional significance of two forms of Go a subunit is
not clear. Masters et al. (32) have shown that the C-terminal
40% ofGsa subunit contains the structural elements required
for specific interactions with effector and receptor. Perhaps
G0Aa and GoBa interact with different sets of receptors
and/or effectors. Indeed, amino acids 315-327, by analogy to
transducin, are important for receptor interactions (33).
Within this region, GoAa and GoBa differ at 5 positions.
Between amino acids 292 and 307, the two sequences differ
at 11 positions. However, the contribution of this region to G
protein function is not defined.
The list of genes known to encode G proteins is growing.
Many novel a (24), ,8 (ref. 34; E. von Weizsacker and M.I.S.,
unpublished data), and y (35) subunit sequences have been
cloned recently. Alternative splicing provides another means
to increase G protein diversity and thereby to expand the
variety of G protein-mediated signaling events in a multicel-
lular organism.
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